QR kód

Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals

Abstract Cladribine tablets have been granted marketing authorization in Europe and approved by the Food and Drug Administration (FDA) in the USA to treat relapsing forms of multiple sclerosis (MS). However, people with MS (PwMS) may be more familiar, and therefore more confident, with treatments re...

Celý popis

Uloženo v:
Hlavní autoři: Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Médium: Artigo
Jazyk:Inglês
Vydáno: Adis, Springer Healthcare 2024-05-01
Edice:Neurology and Therapy
Témata:
Cladribine tablets
Disease-modifying therapy
Education
Multiple sclerosis
Personalized care
Health literacy
On-line přístup:https://doi.org/10.1007/s40120-024-00608-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky